Citadel Advisors
IVC

Citadel Advisors’s Invacare Corporation IVC Stock Holding History

Citadel Advisors’s Portfolio IVC Stock Details IVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,200
Closed -$9K – 15775
2022
Q3 		$9K Sell
11,200
-2,800
-20% -$2.95K ﹤0.01% 12302
2022
Q2 		$18K Sell
14,000
-2,300
-14% -$3.03K ﹤0.01% 12451
2022
Q1 		$23K Buy
16,300
+6,300
+63% +$13.5K ﹤0.01% 13213
2021
Q4 		$27K Sell
10,000
-36,800
-79% -$136K ﹤0.01% 13514
2021
Q3 		$223K Buy
46,800
+20,900
+81% +$153K ﹤0.01% 11754
2021
Q2 		$209K Buy
25,900
+5,800
+29% +$48.3K ﹤0.01% 12060
2021
Q1 		$161K Buy
20,100
+7,400
+58% +$68.9K ﹤0.01% 11962
2020
Q4 		$114K Buy
+12,700
New +$106K ﹤0.01% 10143

Other funds holding IVC

Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's IVC Position: Q3 2022 in Review

Citadel Advisors sold out of Invacare Corporation (IVC) in Q3 2022, closing a stake of 128,707 shares — an estimated $135K sold.

Citadel Advisors first reported a position in IVC in Q2 2013 and held it in 31 quarters. The position peaked at $4.21M in Q2 2018. 72 funds tracked by Wall St. Rank hold IVC as of Q3 2022.

  • Citadel Advisors reported no remaining Invacare Corporation position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 128,707 Invacare Corporation shares in Q3 2022, an estimated $135K.
  • Citadel Advisors first reported a position in Invacare Corporation in Q2 2013 and held it in 31 quarters.
  • Citadel Advisors's Invacare Corporation position peaked at $4.21M in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Invacare Corporation as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.